HCG703.50

Healthcare Global Enterprises Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹10,123 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
HCG
FY26
APOLLOHOSP
FY26
FORTIS
FY26
RAINBOW
FY26
Peer
Median
Valuation — at last close
P/E725.26×65.86×65.36×53.34×65.36× +1010%
P/B7.18×12.82×6.70×8.92×8.92× -20%
EV/EBITDA22.54×34.95×33.84×26.48×33.84× -33%
Market Cap₹10,123 Cr₹1.28L Cr₹68,097 Cr₹14,848 Cr₹68,097 Cr -85%
Growth
Revenue CAGR 3Y14.53%14.94%13.17%13.22%13.22% +10%
Revenue CAGR 5Y20.22%19.03%17.76%18.40% +10%
Net Income CAGR 3Y8.94%33.35%18.91%9.85%18.91% -53%
Revenue YoY (latest Q)13.36%20.56%17.46%33.17%20.56% -35%
Net Income YoY (latest Q)175.25%38.41%2.26%16.23%16.23% +980%
Profitability
EBITDA Margin18.30%14.94%22.84%31.95%22.84% -20%
Net Income Margin0.89%7.94%11.66%16.53%11.66% -92%
Return on Common Equity0.98%19.47%10.25%16.73%16.73% -94%
Return on Capital Employed7.54%18.41%11.81%15.19%15.19% -50%
Return on Assets0.58%9.02%6.67%10.15%9.02% -94%
Credit & Quality
Total Debt/Equity0.65×0.57×0.28×0.00×0.28× +132%
Interest Coverage1.26×6.44×5.20×5.07×5.20× -76%
Scale — latest FY
Revenue / Total Income₹2,545 Cr₹25,229 Cr₹9,128 Cr₹1,703 Cr₹9,128 Cr -72%
Net Income₹22.8 Cr₹2,003 Cr₹1,064 Cr₹282 Cr₹1,064 Cr -98%
Total Assets₹3,923 Cr₹22,197 Cr₹15,966 Cr₹2,775 Cr₹15,966 Cr -75%
EPS₹0.97₹135.04₹13.8₹27.41₹27.41 -96%
Book Value per Share₹98₹693.64₹134.69₹163.81₹163.81 -40%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.